Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on July 1, 2025

Diabetes stocks rally after RFK comments on HHS campaign

TipRanks

6 days ago

Diabetes stocks rally after RFK comments on HHS campaign

Argus Research

7 days ago

PODD: Raising target price to $326.00

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Barchart

7 days ago

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Business Wire

13 days ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

TipRanks

14 days ago

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

Investing.com

15 days ago

Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth

MT Newswires

15 days ago

Truist Initiates Insulet at Buy With $365 Price Target

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of

StockStory

19 days ago

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility

Simply Wall St.

20 days ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility

Here's Why You Should Retain PODD Stock in Your Portfolio Now

Zacks

20 days ago

Here's Why You Should Retain PODD Stock in Your Portfolio Now

Argus Research

21 days ago

PODD: Rating decreased to a HOLD

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Business Wire

21 days ago

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption

StockStory

22 days ago

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

3 Reasons Investors Love Insulet (PODD)

StockStory

a month ago

3 Reasons Investors Love Insulet (PODD)

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

StockStory

a month ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

Here's Why Insulet (PODD) is a Strong Growth Stock

Zacks

a month ago

Here's Why Insulet (PODD) is a Strong Growth Stock

MT Newswires

a month ago

TD Cowen Adjusts Price Target on Insulet to $379 From $324

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

Zacks

a month ago

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

StockStory

a month ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

Solventum Stock Earns RS Rating Upgrade

Investor's Business Daily

a month ago

Solventum Stock Earns RS Rating Upgrade

1 Surging Stock with Exciting Potential and 2 to Question

StockStory

a month ago

1 Surging Stock with Exciting Potential and 2 to Question

Investing.com

a month ago

Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy

MT Newswires

a month ago

Goldman Sachs Initiates Insulet at Buy With $380 Price Target

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

Simply Wall St.

a month ago

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

MT Newswires

a month ago

Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Zacks

a month ago

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Business Wire

a month ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

Zacks

a month ago

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

MT Newswires

a month ago

Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating

4 Medical Product Stocks to Watch From a Challenging Industry

Zacks

a month ago

4 Medical Product Stocks to Watch From a Challenging Industry

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

MT Newswires

2 months ago

Bernstein Adjusts Insulet Price Target to $375 From $355

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

2 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

MT Newswires

2 months ago

Insulet Insider Sold Shares Worth $960,320, According to a Recent SEC Filing

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

Insider Monkey

2 months ago

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

Outlier Money Flows Lift Insulet

FX Empire

2 months ago

Outlier Money Flows Lift Insulet

1 Mid-Cap Stock to Target This Week and 2 to Avoid

StockStory

2 months ago

1 Mid-Cap Stock to Target This Week and 2 to Avoid

Argus Research

2 months ago

PODD: Raising target price to $346.00

MT Newswires

2 months ago

Morgan Stanley Adjusts Price Target on Insulet to $355 From $325, Maintains Overweight Rating

Insulet Announces Publication of 2024 Sustainability Report

Business Wire

2 months ago

Insulet Announces Publication of 2024 Sustainability Report

MT Newswires

2 months ago

Wolfe Research Upgrades Insulet to Outperform From Peer Perform, Price Target is $350

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

Zacks

2 months ago

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

MT Newswires

2 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $350 From $315, Maintains Buy Rating

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

Investor's Business Daily

2 months ago

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Investopedia

2 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Investor's Business Daily

2 months ago

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Why Insulet (PODD) Stock Is Trading Up Today

StockStory

2 months ago

Why Insulet (PODD) Stock Is Trading Up Today

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Investopedia

2 months ago

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

Yahoo Finance Video

2 months ago

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Simply Wall St.

2 months ago

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

Investopedia

2 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

MT Newswires

2 months ago

RBC Raises Price Target on Insulet to $330 From $325, Keeps Outperform Rating

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Insulet Corp Earnings Call

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

Investor's Business Daily

2 months ago

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

MT Newswires

2 months ago

Canaccord Genuity Lifts Price Target on Insulet to $331 From $324, Maintains Buy Rating

MT Newswires

2 months ago

Oppenheimer Adjusts Price Target on Insulet to $324 From $312, Maintains Outperform Rating

MT Newswires

2 months ago

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating

MT Newswires

2 months ago

Wells Fargo Adjusts Price Target on Insulet to $330 From $322, Maintains Overweight Rating

MT Newswires

2 months ago

Bernstein Adjusts Price Target on Insulet to $355 From $335, Maintains Outperform Rating

What To Expect From Insulet’s (PODD) Q1 Earnings

StockStory

2 months ago

What To Expect From Insulet’s (PODD) Q1 Earnings

Argus Research

2 months ago

PODD: Raising target price to $285.00

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Zacks

2 months ago

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

StockStory

2 months ago

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

MT Newswires

2 months ago

Insulet Shares Fall After Wolfe Research Downgrade

MT Newswires

2 months ago

Wolfe Research Downgrades Insulet to Peer Perform From Outperform

Insulet Names New CEO, Expects to Top Revenue Projections

Investopedia

2 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

Ashley McEvoy named Insulet CEO

MedTech Dive

2 months ago

Ashley McEvoy named Insulet CEO

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

StockStory

2 months ago

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

MT Newswires

2 months ago

Insulate Names Ashley McEvoy Chief Executive

Insulet Appoints Ashley McEvoy President and CEO

Business Wire

2 months ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

2 months ago

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Argus Research

2 months ago

PODD: Raising target price to $297.00

4 Medical Product Stocks to Buy From a Challenging Industry

Zacks

2 months ago

4 Medical Product Stocks to Buy From a Challenging Industry

Argus Research

3 months ago

PODD: Raising target price to $282.00

MT Newswires

3 months ago

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

StockStory

3 months ago

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

Zacks

3 months ago

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Zacks

3 months ago

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Argus Research

3 months ago

PODD: Lowering target price to $272.00

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Zacks

3 months ago

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

3 months ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Investor's Business Daily

3 months ago

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Simply Wall St.

3 months ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

MT Newswires

3 months ago

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

CNW Group

3 months ago

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Business Wire

3 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

StockStory

3 months ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Argus Research

3 months ago

PODD: Lowering target price to $290.00

3 Reasons Investors Love Insulet (PODD)

StockStory

3 months ago

3 Reasons Investors Love Insulet (PODD)

MT Newswires

3 months ago

Insulet Insider Sold Shares Worth $501,875, According to a Recent SEC Filing

Argus Research

3 months ago

PODD: Rating increased to a BUY

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Zacks

3 months ago

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Simply Wall St.

3 months ago

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Zacks

3 months ago

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

3 months ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

Zacks

3 months ago

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Zacks

3 months ago

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Share on Social Networks: